109 related articles for article (PubMed ID: 6414103)
1. Persistence of impaired PRL responses to sulpiride in patients with PRL secreting pituitary adenomas after successful hypophysectomy.
Hanew K; Sasaki A; Sato S; Kasai M; Murata K; Shimizu Y; Murakami O; Yoshinaga K
Tohoku J Exp Med; 1983 Jul; 140(3):225-33. PubMed ID: 6414103
[TBL] [Abstract][Full Text] [Related]
2. [The properties of prolactin secretion in patients with prolactin secreting pituitary adenomas].
Sato S
Nihon Naibunpi Gakkai Zasshi; 1987 Aug; 63(8):947-60. PubMed ID: 3123284
[TBL] [Abstract][Full Text] [Related]
3. The autonomy of prolactin secretion in patients with prolactin producing tumor.
Hanew K; Sasaki A; Sato S; Murata K; Fukui M; Koh K; Shimizu Y; Murakami O; Yoshinaga K
Tohoku J Exp Med; 1982 May; 137(1):101-7. PubMed ID: 6808703
[TBL] [Abstract][Full Text] [Related]
4. The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome.
Jeske W
Acta Endocrinol (Copenh); 1979 Jul; 91(3):385-96. PubMed ID: 112817
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery.
Barbarino A; De Marinis L; Anile C; Menini E; Merlini G; Maira G
Metabolism; 1982 Nov; 31(11):1100-4. PubMed ID: 6813636
[TBL] [Abstract][Full Text] [Related]
6. Abnormal regulation of prolactin secretion after successful surgery for prolactin-secreting pituitary tumours.
Schlechte JA; Sherman BM
Clin Endocrinol (Oxf); 1981 Aug; 15(2):165-74. PubMed ID: 6796301
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of hypothalamic hyperprolactinemia.
Ferrari C; Rampini P; Benco R; Caldara R; Scarduelli C; Crosignani PG
J Clin Endocrinol Metab; 1982 Nov; 55(5):897-901. PubMed ID: 6811605
[TBL] [Abstract][Full Text] [Related]
8. Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests.
Webster J; Page MD; Bevan JS; Richards SH; Douglas-Jones AG; Scanlon MF
Clin Endocrinol (Oxf); 1992 Jan; 36(1):35-44. PubMed ID: 1559298
[TBL] [Abstract][Full Text] [Related]
9. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of pharmacodynamic tests in the hyperprolactinaemic syndrome.
Ayalon D; Persitz E; Ravid R; Jedwab G; Avidan S; Cordova T; Harell A
Clin Endocrinol (Oxf); 1979; 11(2):201-15. PubMed ID: 114343
[TBL] [Abstract][Full Text] [Related]
11. Prolactin-secreting pituitary adenomas: prolactin dynamics before and after transsphenoidal surgery.
Barbarino A; de Marinis L; Menini E; Anile C; Maira G
Acta Endocrinol (Copenh); 1979 Jul; 91(3):397-409. PubMed ID: 112818
[TBL] [Abstract][Full Text] [Related]
12. Evidence for dopamine-related and TRH-related pituitary TSH and PRL pools in patients with prolactinoma.
Hanew K; Utsumi A; Sugawara A; Shimizu Y; Yoshinaga K
Acta Endocrinol (Copenh); 1991 May; 124(5):545-52. PubMed ID: 1903012
[TBL] [Abstract][Full Text] [Related]
13. Subnormal prolactin responsiveness to thyrotropin-releasing hormone (TRH) in women with primary empty sella syndrome.
Celani MF; Giambuzzi G; Simoni M; Montanini V
J Endocrinol Invest; 1987 Aug; 10(4):421-5. PubMed ID: 3119699
[TBL] [Abstract][Full Text] [Related]
14. Prolactin secretion from human prolactinomas perifused in vitro: effect of TRH, prostaglandin E1, theophylline, dopamine and dopamine receptor blockers.
Chihara K; Iwasaki J; Minamitani N; Kaji H; Kodama H; Fujita T; Shirataki K; Tamaki N; Matsumoto S
Acta Endocrinol (Copenh); 1984 Jan; 105(1):6-13. PubMed ID: 6421041
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of dynamic pituitary function testing in patients with hyperprolactinemia on diagnosis of pituitary prolactin-secreting adenoma (author's transl)].
Matsuura K
Nihon Sanka Fujinka Gakkai Zasshi; 1982 May; 34(5):569-78. PubMed ID: 6806416
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.
Moriondo P; Travaglini P; Nissim M; Faglia G
Clin Endocrinol (Oxf); 1980 Dec; 13(6):525-33. PubMed ID: 7226570
[TBL] [Abstract][Full Text] [Related]
17. The use of thyrotropin-releasing hormone in distinguishing prolactin-secreting pituitary adenoma.
Marrs RP; Bertolli SJ; Kletzky OA
Am J Obstet Gynecol; 1980 Nov; 138(6):620-5. PubMed ID: 6776812
[TBL] [Abstract][Full Text] [Related]
18. Prolactin dynamics in a patient with isolated ACTH deficiency accompanied by hyperprolactinemia.
Shibutani Y
Am J Med Sci; 1988 Feb; 295(2):140-3. PubMed ID: 2830786
[TBL] [Abstract][Full Text] [Related]
19. [The combined stimulation test sulpiride-TRH in the investigation of prolactin secretion].
Miras-Mirakian P; Claustrat F; Dechaud H; Pugeat M
J Gynecol Obstet Biol Reprod (Paris); 1992; 21(4):419-23. PubMed ID: 1624729
[TBL] [Abstract][Full Text] [Related]
20. Prolactin dynamics in patients with non-secretin tumours of the hypothalamic-pituitary region.
Barbarino A; De Marinis L; Mancini A; Menini E; D'Amico C; Passeri M; Sambo P; Anile C; Maira G
Acta Endocrinol (Copenh); 1985 Sep; 110(1):10-6. PubMed ID: 3929517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
